Inzucchi SE - Search Results

1

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.

Bohula EA, Wiviott SD, McGuire DK, Inzucchi SE, Kuder J, Im K, Fanola CL, Qamar A, Brown C, Budaj A, Garcia-Castillo A, Gupta M, Leiter LA, Weissman NJ, White HD, Patel T, Francis B, Miao W, Perdomo C, Dhadda S, Bonaca MP, Ruff CT, Keech AC, Smith SR, Sabatine MS, Scirica BM; CAMELLIA–TIMI 61 Steering Committee and Investigators. Bohula EA, et al. Among authors: inzucchi se. N Engl J Med. 2018 Sep 20;379(12):1107-1117. doi: 10.1056/NEJMoa1808721. Epub 2018 Aug 26. N Engl J Med. 2018. PMID: 30145941 Free article. Clinical Trial.

2

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI. Inzucchi SE, et al. N Engl J Med. 1998 Mar 26;338(13):867-72. doi: 10.1056/NEJM199803263381303. N Engl J Med. 1998. PMID: 9516221 Free article. Clinical Trial.

3

Clinical practice. Management of hyperglycemia in the hospital setting.

Inzucchi SE. Inzucchi SE. N Engl J Med. 2006 Nov 2;355(18):1903-11. doi: 10.1056/NEJMcp060094. N Engl J Med. 2006. PMID: 17079764 Review. No abstract available.

4

Metformin therapy in patients with type 2 diabetes complicated by heart failure.

Inzucchi SE, Masoudi FA, McGuire DK. Inzucchi SE, et al. Am Heart J. 2007 Dec;154(6):e45. doi: 10.1016/j.ahj.2007.09.013. Epub 2007 Oct 25. Am Heart J. 2007. PMID: 18035066 No abstract available.

5

Metformin in heart failure.

Inzucchi SE, Masoudi FA, McGuire DK. Inzucchi SE, et al. Diabetes Care. 2007 Dec;30(12):e129. doi: 10.2337/dc07-1686. Diabetes Care. 2007. PMID: 18042738 No abstract available.

6

New drugs for the treatment of diabetes mellitus: part I: Thiazolidinediones and their evolving cardiovascular implications.

McGuire DK, Inzucchi SE. McGuire DK, et al. Among authors: inzucchi se. Circulation. 2008 Jan 22;117(3):440-9. doi: 10.1161/CIRCULATIONAHA.107.704080. Circulation. 2008. PMID: 18212301 Review. No abstract available.

7

New drugs for the treatment of diabetes: part II: Incretin-based therapy and beyond.

Inzucchi SE, McGuire DK. Inzucchi SE, et al. Circulation. 2008 Jan 29;117(4):574-84. doi: 10.1161/CIRCULATIONAHA.107.735795. Circulation. 2008. PMID: 18227398 Review.

8

Five-year outcomes in high-risk participants in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study: a post hoc analysis.

Bansal S, Wackers FJ, Inzucchi SE, Chyun DA, Davey JA, Staib LH, Young LH; DIAD Study Investigators. Bansal S, et al. Among authors: inzucchi se. Diabetes Care. 2011 Jan;34(1):204-9. doi: 10.2337/dc10-1194. Epub 2010 Oct 7. Diabetes Care. 2011. PMID: 20929989 Free PMC article.

9

Gender-based divergence of cardiovascular outcomes in asymptomatic patients with type 2 diabetes: results from the DIAD study.

Tandon S, Wackers FJ, Inzucchi SE, Bansal S, Staib LH, Chyun DA, Davey JA, Young LH; DIAD Investigators. Tandon S, et al. Among authors: inzucchi se. Diab Vasc Dis Res. 2012 Apr;9(2):124-30. doi: 10.1177/1479164111431470. Epub 2012 Jan 6. Diab Vasc Dis Res. 2012. PMID: 22228772 Free article. Clinical Trial.

10

Clinical practice. Diagnosis of diabetes.

Inzucchi SE. Inzucchi SE. N Engl J Med. 2012 Aug 9;367(6):542-50. doi: 10.1056/NEJMcp1103643. N Engl J Med. 2012. PMID: 22873534 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

445 results

Search Page